4.7 Article

Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with β-cyclodextrin

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 316, 期 1-2, 页码 29-36

出版社

ELSEVIER
DOI: 10.1016/j.ijpharm.2006.02.035

关键词

ginseng saponin metabolite (IH901); cyclodextrin; inclusion complex; phase solubility; physicochemical characteristics; pharmacokinetics; HPLC; LC/MS/MS

向作者/读者索取更多资源

In an effort to improve the bioavailability (BA) of the insoluble compound 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol (IH901), we prepared beta-cyclodextrin (beta CD) and hydroxypropyl-beta-cyclodextrin (HP beta CD) inclusion complexes containing IH901.1H901 is a major metabolite formed by intestinal bacteria from protopanaxadiol ginseng saponins. We developed and validated an HPLC-based method to measure IH901 levels from samples prepared in vitro. The phase solubility profiles with both cyclodextrins (CDs) were classified as A(L)-type, indicating the formation of a 1:1 stoichiometric inclusion complex. Stability constants (K-s) calculated from the phase solubility diagrams showed that the beta CD complex was more stable than the HP beta CD complex. Consequently, complexes of IH901 and beta CD were prepared by a freeze-drying method and were analyzed by fourier transformation-infrared spectroscopy (FT-IR), X-ray diffraction, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). From these physicochemical characterizations, we confirmed the presence of a new solid phase in the freeze-dried samples. The IH901 released from the complex in a pH 1.2 solution, the pH range of gastric fluids, was considerably lower than the amount released in the other solutions. The IH901 released from the complex in pH 6.8 solution, the range of intestinal fluids, was 9.0-fold greater than pure IH901 powder. However, the amount of IH901 released from the complex in pH 4.0-8.0 was less than 20%. After oral administration of the IH901-beta CD inclusion complex (30 mg/kg IH901) into rats, plasma concentrations were determined by LC/MS/MS. The peak concentration (C,n) for the inclusion complex was 2.8-fold higher than that for pure IH901 powder. The BA, calculated from the ratio of the AUC(oral), to the AUC(i.v.), for the pure IH901 powder, the IH901-beta CD physical mixture, and the inclusion complex was 3.52, 4.34, and 6.57%, respectively. These results indicate that the BA for the inclusion complex was 1.9-fold higher than that for the pure IH901 powder. (c) 2006 Elsevier B.V All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据